Table 1 Characteristics of HIV-infected patients receiving cART.
From: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
Patients | Gender | Age (years) | CD4+ T cell count (cells/μl) | ART regimen | Duration of therapy (years) | Duration of viral suppression (<40 copies/ml of plasma HIV-1 RNA) (months) |
|---|---|---|---|---|---|---|
1 | Male | 51 | 568 | AZT + 3TC + EFV | 5 | 39 |
2 | Male | 59 | 541 | TDF + 3TC + LPV/R | 2 | 14 |
3 | Male | 31 | 455 | AZT + 3TC + NVP | 8 | 43 |
4 | Male | 43 | 453 | AZT + 3TC + EFV | 3 | 27 |
5 | Male | 46 | 388 | AZT + 3TC + EFV | 4 | 17 |
6 | Male | 35 | 451 | TDF + 3TC + EFV | 3 | 30 |
7 | Male | 29 | 417 | AZT + 3TC + EFV | 4 | 40 |
